Socioeconomic Deprivation and Peripheral Arterial Disease
NCT ID: NCT03693053
Last Updated: 2018-10-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
150 participants
OBSERVATIONAL
2017-10-02
2018-07-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
PAD is a serious illness and an important predictor of cardiovascular disease with major medico-economic consequences.
A low socioeconomic status (SES) is associated with higher cardiovascular mortality and morbidity. In these vulnerable populations, there is an increase in the prevalence of cardiovascular risk factors, particularly for smoking.
The main objective of this study was to assess the level of precariousness in patients with symptomatic PAD and compare it to the level of precariousness in the general population.
Patients were recruited from vascular medicine and surgery department of Grenoble university hospital or therapeutic education outpatient consultation.
The analysis of socio-economic and environmental data resulted in:
\- EPICES score: (Evaluation of the Deprivation and Inequalities of Health in Healthcare Centers score). The EPICES score is a quick and validated questionnaire to assess precariousness at the individual level, developed by considering all the material and psychosocial dimensions of precariousness.
Precariousness, according to the EPICES score, in the general population is estimated at 40%.
\- INSEE parameters. The investigators completed the EPICES score with more traditional indicators derived from The National Institute of Statistics and Economic Studies (INSEE) collects, analyses and disseminates information on the French economy and society. The investigators collected the level of education and professional practice based on the nomenclature of socio-professional categories defined by INSEE.
Cardiovascular risk factors were also collected to measure the links between the level of precariousness and cardiovascular risk factors.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Etiology and Prevalence of Peripheral Arterial Disease
NCT00005142
Novel Risk Factors and Localization of Peripheral Arterial Disease
NCT07233356
Mechanisms of Disability in Peripheral Arterial Disease
NCT00046592
Early Detection of Arteriosclerosis
NCT00863967
Low Health Literacy Prevalence's Study in Patients With Chronic Cardiovascular Disease
NCT03952013
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 years or older,
* Symptomatic PAD (stage 2 or 3)
Exclusion Criteria
* Person under administrative or judicial supervision
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Grenoble
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital
Grenoble, Isere, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-A02063-50
Identifier Type: OTHER
Identifier Source: secondary_id
38RC17.212
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.